Fonar wins $110 mil. award in MRI patent infringement suit; GE will appeal.
This article was originally published in The Gray Sheet
Executive Summary
FONAR WINS $110 MIL. AWARD IN MRI PATENT SUIT WITH GE under a jury award handed down May 26 in the U.S. District Court for Eastern New York. Fonar had been seeking over $300 mil. in lost profits and royalties for General Electric Medical Systems' infringement on two patents covering Fonar's magnetic resonance imaging technology.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.